524 related articles for article (PubMed ID: 21070500)
1. Orthopaedic evaluation in children with severe haemophilia A or B submitted to primary prophylaxis therapy in a coagulopathy treatment centre.
De Podestá Haje D; Ono F; De Oliveira GB; Almeida J; De Paula JC; Batista Neto LV; Silva Barros SB
Haemophilia; 2011 Mar; 17(2):228-32. PubMed ID: 21070500
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of joint damage in hemophilic children with early prophylaxis].
Kreuz W; Escuriola Ettingshausen C; Funk M; Pons S; Schmidt H; Kornhuber B
Orthopade; 1999 Apr; 28(4):341-6. PubMed ID: 10335528
[TBL] [Abstract][Full Text] [Related]
3. Haemophilia prophylaxis in young patients--a long-term follow-up.
Löfqvist T; Nilsson IM; Berntorp E; Pettersson H
J Intern Med; 1997 May; 241(5):395-400. PubMed ID: 9183307
[TBL] [Abstract][Full Text] [Related]
4. The overall effectiveness of prophylaxis in severe haemophilia.
Panicker J; Warrier I; Thomas R; Lusher JM
Haemophilia; 2003 May; 9(3):272-8. PubMed ID: 12694517
[TBL] [Abstract][Full Text] [Related]
5. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.
Nilsson IM; Berntorp E; Löfqvist T; Pettersson H
J Intern Med; 1992 Jul; 232(1):25-32. PubMed ID: 1640190
[TBL] [Abstract][Full Text] [Related]
6. The use of prophylaxis in 2663 children and adults with haemophilia: results of the 2006 Canadian national haemophilia prophylaxis survey.
Biss TT; Chan AK; Blanchette VS; Iwenofu LN; McLimont M; Carcao MD; ;
Haemophilia; 2008 Sep; 14(5):923-30. PubMed ID: 18637844
[TBL] [Abstract][Full Text] [Related]
7. Progression of haemophilic arthropathy in children: a Lithuanian--Danish comparative study.
Saulyte Trakymiene S; Clausen N; Poulsen LH; Ingerslev J; Rageliene L
Haemophilia; 2013 Mar; 19(2):212-8. PubMed ID: 23167920
[TBL] [Abstract][Full Text] [Related]
8. Radiologic evaluation of prophylaxis in severe haemophilia.
Pettersson H; Nilsson IM; Hedner U; Noréhn K; Ahlberg A
Acta Paediatr Scand; 1981 Jul; 70(4):565-70. PubMed ID: 6797235
[TBL] [Abstract][Full Text] [Related]
9. When should prophylactic treatment in patients with haemophilia A and B start?--The German experience.
Kreuz W; Escuriola-Ettingshausen C; Funk M; Schmidt H; Kornhuber B
Haemophilia; 1998 Jul; 4(4):413-7. PubMed ID: 9873763
[TBL] [Abstract][Full Text] [Related]
10. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
Taki M; Shirahata A
Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
[TBL] [Abstract][Full Text] [Related]
11. Identification and long-term observation of early joint damage by magnetic resonance imaging in clinically asymptomatic joints in patients with haemophilia A or B despite prophylaxis.
Olivieri M; Kurnik K; Pfluger T; Bidlingmaier C
Haemophilia; 2012 May; 18(3):369-74. PubMed ID: 22032268
[TBL] [Abstract][Full Text] [Related]
12. Low dose secondary prophylaxis reduces joint bleeding in severe and moderate haemophilic children: a pilot study in China.
Wu R; Luke KH; Poon MC; Wu X; Zhang N; Zhao L; Su Y; Zhang J
Haemophilia; 2011 Jan; 17(1):70-4. PubMed ID: 20579111
[TBL] [Abstract][Full Text] [Related]
13. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic treatment with clotting factor to prevent joint damage in patients with severe haemophilia: costs versus benefits].
Roosendaal G; Lafeber FP
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2606-8. PubMed ID: 18161260
[TBL] [Abstract][Full Text] [Related]
15. Is on-demand treatment effective in patients with severe haemophilia?
Aznar JA; Marco A; Jiménez-Yuste V; Fernández-Fontecha E; Pérez R; Soto I; Parra R; Moreno M; Mingot ME; Moret A;
Haemophilia; 2012 Sep; 18(5):738-42. PubMed ID: 22537601
[TBL] [Abstract][Full Text] [Related]
16. The orthopaedic status of severe haemophiliacs in Spain.
Aznar JA; Magallón M; Querol F; Gorina E; Tusell JM
Haemophilia; 2000 May; 6(3):170-6. PubMed ID: 10792475
[TBL] [Abstract][Full Text] [Related]
17. Forum on: the role of recombinant factor VIII in children with severe haemophilia A.
Franchini M; Coppola A; Molinari AC; Santoro C; Schinco P; Speciale V; Tagliaferri A
Haemophilia; 2009 Mar; 15(2):578-86. PubMed ID: 19187188
[TBL] [Abstract][Full Text] [Related]
18. [The orthopaedic status of a selected severe haemophilia group].
Windyga J; Stefańska E; Lopaciuk S; Juszyński A; Woźniak D; Strzelecki O
Pol Arch Med Wewn; 2005 Jun; 113(6):562-9. PubMed ID: 16454446
[TBL] [Abstract][Full Text] [Related]
19. Primary prophylaxis in children with haemophilia.
Coppola A; Di Capua M; De Simone C
Blood Transfus; 2008 Sep; 6 Suppl 2(Suppl 2):s4-11. PubMed ID: 19105503
[TBL] [Abstract][Full Text] [Related]
20. Intraarticular bleeding in children with hemophilia: the prevention of arthropathy.
Gregosiewicz A; Wośko I; Kandzierski G
J Pediatr Orthop; 1989; 9(2):182-5. PubMed ID: 2494223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]